When administering zolpidem to an older adult client, which computer documentation indicates that the desired outcome has been achieved?

A. Exhibits fewer emotional outbursts: Zolpidem is a sedative-hypnotic medication primarily used to treat insomnia. A reduction in emotional outbursts is not a direct expected outcome of this medication. While improved sleep might indirectly influence mood, it is not the primary therapeutic goal.

B. Decreased episodes of incontinence: Zolpidem's primary action is on the central nervous system to promote sleep. A decrease in episodes of incontinence is not a direct pharmacological effect of zolpidem.

C. Improved ability to concentrate: Zolpidem is a sedative and can potentially cause daytime drowsiness or cognitive impairment rather than improving concentration. Its intended effect is to induce sleep, which could indirectly benefit concentration if the client's difficulty concentrating was due to sleep deprivation, but it's not a direct outcome of the medication itself.

D. Sleeps soundly through the night: The intended therapeutic effect of zolpidem is to help the client initiate and maintain sleep. Documentation stating that the client sleeps soundly through the night indicates that the medication has achieved its desired outcome.

A. "I should take this medication only when I am having an asthma attack.": Montelukast is not intended for acute asthma attacks. It is a maintenance medication taken daily to reduce airway inflammation and prevent symptoms, not to treat attacks in progress.

B. "This medication will stop an asthma attack immediately.": Montelukast does not act quickly enough to treat acute bronchospasm. Short-acting beta-agonists like albuterol are used for immediate relief during an asthma attack, not leukotriene modifiers.

C. "I will take the tablet every evening to control my asthma.": Montelukast is prescribed as a daily maintenance therapy, typically taken in the evening to help control chronic asthma symptoms and to reduce the frequency and severity of exacerbations over time.

D. "I will not need to use my inhalers twice a day when I start this medicine.": Even after starting montelukast, clients often still need to use inhaled corticosteroids or other maintenance inhalers. Montelukast is an adjunct therapy, not a replacement for inhaled medications.